ZUMZ Stock Gains 15% on Narrower-Than-Expected Q2 Loss, Comps Rise Y/Y

Zumiez Inc. (ZUMZ) shares surged 14.9% after reporting better-than-expected Q2 fiscal 2025 results, with net sales of $214.3 million (up 1.9% YoY) and a narrower loss of $0.06 per share. The retailer posted a 2.5% comparable sales increase, driven by strong 4.2% growth in North America, which offset international declines, alongside a 130 basis point gross margin expansion. This performance, coupled with positive Q3 and full-year 2025 guidance forecasting a return to profitability, signals continued resilience in its core market and effective cost management.

Analysis

Zumiez Inc. (ZUMZ) reported strong fiscal second-quarter 2025 results, signaling a significant operational turnaround that prompted a 14.9% after-market stock increase. The company surpassed consensus estimates with a narrower-than-expected loss of $0.06 per share and a 1.9% year-over-year revenue increase to $214.3 million. The core driver of this performance is the sustained strength in its North America segment, which posted a 4.2% comparable sales increase, marking its sixth consecutive quarter of growth and effectively offsetting a 5.5% decline in international comps. Margin improvement was a key highlight, with the gross margin expanding 130 basis points to 35.5% due to stronger product margins and occupancy cost leverage from store closures. While this was partially offset by a 100-basis-point rise in SG&A as a percentage of sales, the company still achieved a positive operating income of $0.1 million, reversing a loss from the prior year. Most notably, recent performance shows dramatic acceleration, with comparable sales for the 30 days ended September 1 surging 11.2%. This momentum underpins a robust Q3 and full-year 2025 outlook, which projects a return to annual profitability, Q3 comps growth of 5.5-7.5%, and Q3 EPS between $0.19 and $0.29, a substantial increase from the prior year's $0.06.

Key Decisions for Investors

• Investors should consider the accelerating comparable sales, particularly the 13% recent surge in North America, and the strong guidance for a return to full-year profitability as primary indicators of a successful operational turnaround.
• The key risk to monitor is the persistent weakness in the international segment, as any sign of stabilization or improvement in its negative comps could provide a significant additional catalyst for the stock.
• Focus on margin execution, as the company's ability to drive projected net income growth depends on sustaining gross margin expansion while maintaining discipline over SG&A costs, which rose in Q2.
• Given the debt-free balance sheet and active share repurchase program, view management's capital allocation as a signal of confidence in the forward outlook and a direct mechanism for enhancing shareholder value.